SEC Filings TLDR

Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), sold 3,189 shares of common stock on August 4, 2025, at a price of $28.364 per share. The sale was mandated by the company's equity incentive plans to cover tax withholding obligations related to the vesting of Restricted Stock Units. This transactio...

Vahe Kuzoyan, President of ServiceTitan, Inc., reported several transactions involving Class A and Class B Common Stock. On August 4, 2025, Kuzoyan converted 24,598 shares of Class B Common Stock into Class A Common Stock and sold 21,971 shares at a weighted average price of $114.46. On August 5, 2025, he converted an ...

On August 4, 2025, Jason Bengel, the Chief Financial Officer of LendingTree, Inc., engaged in several transactions involving the company's common stock. Bengel acquired 1,399 shares of common stock through the conversion of restricted stock units, which convert on a one-for-one basis. Additionally, he disposed of 401 s...

On August 4, 2025, Sanam Parikh, a director of Tharimmune, Inc., was granted 50,000 stock options. The options have an exercise price of $1.33 per share and expire on August 4, 2035. Half of the options (25,000) vested immediately on the grant date, while the remaining 25,000 will vest on August 4, 2026. Following this...

On August 4, 2025, Sireesh Appajosyula, the CEO and Director of Tharimmune, Inc., acquired 90,000 stock options. These options have an exercise price of $1.33 per share and expire on August 4, 2035. Half of the options (45,000) vested immediately on the grant date, while the remaining 45,000 will vest on August 4, 2026...

Scott Farquhar, a director and ten percent owner of Atlassian Corp, sold a total of 7,665 shares of Class A Common Stock on August 5, 2025. The transactions were executed at weighted-average prices ranging from $183.855 to $186.312 per share. These sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by ...

Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corp, sold a total of 7,665 shares of Class A Common Stock on August 5, 2025. The transactions were executed at weighted-average prices ranging from $183.855 to $186.312 per share. These sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Cannon...

On August 4, 2025, Matthew Cohn, a director of Bancorp, Inc., reported changes in his ownership of the company's common stock. Cohn directly owns 59,611 shares and indirectly owns shares through trusts and family members. The indirect ownership includes 161,444 shares held by trusts, 2,549 shares held by one daughter, ...

On August 4, 2025, Todd Krasnow, a director of Symbotic Inc., engaged in several transactions involving the company's Class A and Class V-1 Common Stock. Krasnow sold 4,000 shares of Class A Common Stock pursuant to a Rule 10b5-1 trading plan, which was entered into on February 19, 2025. In connection with this sale, K...

On August 5, 2025, Bilal Arif, Chief Tech Ops Officer of Sarepta Therapeutics, Inc., earned 6,250 Performance Stock Units (PSUs) based on the company's achievement of prescribed milestones. These PSUs, granted on March 1, 2024, will vest on March 1, 2026, contingent on Arif's continued service with the company. The tra...

Ian Michael Estepan, Chief Operating Officer of Sarepta Therapeutics, Inc., was awarded 6,250 Performance Stock Units (PSUs) on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the company's achievement of prescribed milestones. These PSUs will vest on March 1, 2026, ...

On August 5, 2025, Louise Rodino-Klapac, President of R&D and Tech Ops at Sarepta Therapeutics, Inc., was awarded 6,250 Performance Stock Units (PSUs). These PSUs were granted on March 1, 2024, and the number of shares earned is based on the Compensation Committee's determination of the company's achievement of prescri...

On August 4, 2025, Isaac P. Torres, a director of 1ST SOURCE CORP, acquired 230 shares of the company's common stock at a price of $60.68 per share. Following this transaction, Torres owns a total of 10,531 shares directly. This acquisition was reported in a Form 4 filing with the SEC. The transaction is significant as...

On August 4, 2025, Ronda Shrewsbury, a director of 1ST SOURCE CORP, purchased 263 shares of the company's common stock at a price of $60.68 per share. Following this transaction, Shrewsbury's total ownership in the company increased to 12,452 shares. The transaction was reported under Form 4, indicating a direct owners...

On August 4, 2025, Todd F. Schurz, a director of 1ST SOURCE CORP (SRCE), acquired 230 shares of the company's common stock at a price of $60.68 per share. Following this transaction, Schurz's total holdings in the company increased to 13,849 shares. This acquisition was made directly by Schurz, as indicated by the owne...

On August 4, 2025, Tracy D. Graham, a director of 1ST SOURCE CORP, acquired 230 shares of the company's common stock at a price of $60.68 per share. Following this transaction, Graham owns a total of 12,486 shares directly. This filing, submitted on August 6, 2025, indicates that Graham is not an officer or a ten perce...

John F. Affleck-Graves, a director of 1ST SOURCE CORP, purchased 263 shares of the company's common stock on August 4, 2025. The transaction was priced at $60.68 per share, totaling approximately $15,958.84. Following this transaction, Affleck-Graves owns 19,605 shares of the company's common stock. This purchase was m...

Mark D. Schwabero, a director of 1st Source Corp, acquired 181 shares of the company's common stock on August 4, 2025, at a price of $60.68 per share. Following this transaction, Schwabero's total holdings in 1st Source Corp increased to 28,479 shares. The acquisition was made directly by Schwabero, as indicated by the...

On August 4, 2025, Timothy K. Ozark, a director of 1ST SOURCE CORP (ticker: SRCE), acquired 313 shares of the company's common stock at a price of $60.68 per share. Following this transaction, Ozark owns a total of 49,829 shares of the company's common stock directly. This acquisition was reported in a Form 4 filing wi...

Justyn R. Howard, the Executive Chair and a 10% owner of Sprout Social, Inc., reported several transactions involving the company's Class A and Class B common stock on August 5, 2025. These transactions were executed under a 10b5-1 plan adopted on September 10, 2024. Howard acquired 20,000 shares of Class A Common Stoc...

Joseph Del Preto, the CFO and Treasurer of Sprout Social, Inc., sold 1,500 shares of Class A Common Stock on August 5, 2025, at a weighted average price of $16.418 per share. The shares were sold under a 10b5-1 plan adopted on August 20, 2024. Following the transaction, Del Preto owns 247,012 shares, which include vari...

Todd J Stein, a director of Spok Holdings, Inc., reported several transactions involving the company's common stock. On August 4, 2025, Stein indirectly sold 70,020 shares at $18.6320 per share through Braeside Investments, LLC, reducing his holdings to 77,865 shares. The following day, he sold an additional 4,500 shar...

On August 5, 2025, Calvin Rice, the Chief Financial Officer & CAO of Spok Holdings, Inc., reported the sale of 14,736 shares of the company's common stock at a price of $18.281 per share. Following this transaction, Rice owns 7,035 shares of common stock directly. Additionally, Rice holds 56,059 restricted stock units ...

Elizabeth A. Howe, EVP and Chief Financial Officer of SiTime Corp, sold 1,500 shares of common stock on August 6, 2025, at a price of $208 per share. Following this transaction, Howe owns 71,474 shares of common stock, which includes 62,311 shares issuable pursuant to previously reported restricted stock units and perf...

On August 4, 2025, Jeffrey W. Dunn, a director of SI-BONE, Inc., sold 293 shares of common stock at a weighted average price of $17.3743 per share. This sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units and was executed through a 'sell to cover' transaction, which ...